Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123273) titled 'Efficacy and Safety Study of Efgartigimod in the Treatment of Acute Episodes of Neuromyelitis Optica Spectrum Disorders' on April 23.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The Third Affiliated Hospital Sun Yat-sen University
Condition:
Neuromyelitis Optica Spectrum Disorders
Intervention:
Efgartigimod combined with IVMP group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-24
Target Sample Size: Efgartigimod combined with IVMP group:30;IVMP group:30;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org....